Details of Data Requests to Use Johnson and Johnson Data
Request listing updated daily
All Requests
The YODA Project posts proposals once data access has been granted or denied.
443 results returned displaying 1 to 10 of 443
Filters list
Published
Publications Available! See more below
Biomarkers for Predicting Long-term Outcomes in Ulcerative Colitis
Principal Investigator
Protocol & Associated Materials
Protocol #2022-5104 Proposal (PDF) Protocol #2022-5104 Review (PDF) Protocol #2022-5104 Due Diligence Assessment (PDF)
Ongoing
Publication Available!
External Validation of a Prognostic Model of Overall Survival In Men with Metastatic Castration-Resistant Prostate Cancer
Principal Investigator
Reports & Publications
J Clin Oncol . 2023Protocol & Associated Materials
Protocol #2021-4846 Proposal (PDF) Protocol #2021-4846 Review (PDF) Protocol #2021-4846 Due Diligence Assessment (PDF)
Ongoing
Publication Available!
Comparative Efficacy of Ustekinumab and Infliximab on One Year Outcomes Among Biologic-nave Induction Responders in Crohn’s Disease
Principal Investigator
Reports & Publications
Inflamm Bowel Dis. 2022Cited By
View 9 CitationsProtocol & Associated Materials
Protocol #2021-4822 Proposal (PDF) Protocol #2021-4822 Review (PDF) Protocol #2021-4822 Due Diligence Assessment (PDF)
Published
Publications Available! See more below
Predictors of Placebo Response and Remission in Ulcerative Colitis and Crohn’s Disease
Principal Investigator
Cited By
View 2 CitationsProtocol & Associated Materials
Protocol #2021-4779 Proposal (PDF) Protocol #2021-4779 Review (PDF) Protocol #2021-4779 Due Diligence Assessment (PDF)
Published
Publication Availible!
Comparative Effectiveness of Biologics for Endoscopic Healing of the Ileum and Colon in Crohn’s Disease
Principal Investigator
Reports & Publications
AJG 2022Cited By
View 14 CitationsProtocol & Associated Materials
Protocol #2021-4778 Review (PDF) Protocol #2021-4778 Due Diligence Assessment (PDF)
Published
Publication Available!
A Comparison of the Rapidity of Clinical Response between Infliximab and Tofacitinib for Ulcerative Colitis.
Principal Investigator
Reports & Publications
Digestive Diseases and SciencesProtocol & Associated Materials
Protocol #2021-4757 Proposal (PDF) Protocol #2021-4757 Review (PDF) Protocol #2021-4757 Due Diligence Assessment (PDF)
Published
Publications Available!
Dominant Patient Reported Outcomes on Predicting Mucosal Healing in Crohn’s Disease
Principal Investigator
Cited By
View 4 CitationsProtocol & Associated Materials
Protocol #2021-4684 Proposal (PDF) Protocol #2021-4684 Review (PDF) Protocol #2021-4684 Due Diligence Assessment (PDF)
Published
Publication Available!
Data-sharing and re-analysis for main studies assessed by the European Medicines Agency – a cross-sectional study on EPARs
Principal Investigator
Reports & Publications
BMC 2023Protocol & Associated Materials
Protocol #2021-4637 Proposal (PDF) Protocol #2021-4637 Review (PDF) Protocol #2021-4637 Due Diligence Assessment (PDF)
Published
Publication Available!
Modified Multiplier SES-CD (MM-SES-CD) on Predicting Endoscopic Remission in Crohn’s Disease
Principal Investigator
Reports & Publications
Journal of Chron’s & ColitisCited By
View 4 CitationsProtocol & Associated Materials
Protocol #2021-4602 Proposal (PDF) Protocol #2021-4602 Review (PDF) Protocol #2021-4602 Due Diligence Assessment (PDF)
Published
Publication Available!